Q1 2018 SALES: €87.6M LIKE-FOR-LIKE GROWTH UP 5.6%, 0.4% AS REPORTED GROWTH OF ESSENTIALS PRODUCTS: UP 6.8% AS REPORTED
Vetoquinol posted Q1 2018 consolidated sales of €87.6 million, up 5.6% like for like and 0.4% as reported, compared to the same period last year. Negative currency impacts of 5.2% were mainly related to the US and Canadian dollars and the Indian rupee.
- Public releases
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures